Toggle navigation
Home
Search
Services
Blog
Contact
About
Topic 313 Phase I;Rnai Cancer Therapeutics Using Nanotechnology; Hhsn2612013000
Unger, Gretchen
Genesegues, Inc., Chaska, MN, United States
Search 11 grants from Gretchen Unger
Search grants from Genesegues, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Ultra Fast and Sensitive Fluorescence-Based Clinical Assays
Endor Studies of Allosteric Interactions
Estrogen Negative Feedback in Postpartum Lactational Amenorrhea
The Social World of the Oldest Old
Analysis of the Fibronectin Receptor in Fibroblasts
Recently added grants:
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
Quadruplet Decoding for Multiplexed Non-Canonical Amino Acid Incorporation
Lesion-centric optimization of multidrug therapies for tuberculosis
Structure of HIV-1 envelope spike in the context of membrane
Viral factors promoting the release of cell-free HSV-1
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
261201300030C-0-0-1
Application #
8762476
Study Section
Project Start
2013-09-20
Project End
2014-06-19
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$200,000
Indirect Cost
Institution
Name
Genesegues, Inc.
Department
Type
DUNS #
095972415
City
Chaska
State
MN
Country
United States
Zip Code
55318
Comments
Be the first to comment on Gretchen Unger's grant